Biotech Values

[DewDiligence]

MNTA – Here’s an index to some recent posts on anti-
coagulant drugs. The longer it takes for the FDA to
approve generic Lovenox (assuming that they approve
it at all), the less consequential the approval is likely
to be. Newer and better drugs are soon going to take
market share from Lovenox, perhaps abruptly.

#msg-18759853 Overview of the new oral anti-coagulants
#msg-21044989 Rivaroxaban (BAY, JNJ) bests Lovenox in VTE prevention
#msg-19134406 PFE, BMY ink $1B Apixaban collaboration
#msg-21044973 Apixaban non-inferior to Warfarin (phase-2)
#msg-21155926 Dabigatran (BI) non-inferior to Lovenox in VTE prevention
#msg-10569101 Arixtra (GSK) bests Lovenox in ACS